Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04314778 · ClinicalTrials.gov registry record · NA
FITBIT Study on Mobility and Readmissions After Radical Cystectomy
A NA study of Bladder Cancer, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT04314778 is a NA study of Bladder Cancer that has completed, run by University of Pennsylvania. The registered enrollment target is 64 participants, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT04314778, a NA study of Bladder Cancer, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a two-arm randomized, controlled trial during the postoperative period after major abdominal surgery for cancer, including for example radical cystectomy, nephrectomy, colectomy, comparing a control group that uses a wearable device to track physical activity to an intervention group that uses the same wearable devices and receives a supportive social incentive-based gamification intervention to adhere to a step goal program.
Conditions Studied
Interventions
- BEHAVIORAL social incentive-based gamification
Study Locations (2)
Pennsylvania
- Abramson Cancer Center - Philadelphia
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2022-08-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04314778
The ClinicalTrials.gov registry entry for NCT04314778 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 1 intervention - of which social incentive-based gamification is the first listed.
NCT04314778 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04314778 about?
NCT04314778 is a clinical study titled "FITBIT Study on Mobility and Readmissions After Radical Cystectomy". This is a two-arm randomized, controlled trial during the postoperative period after major abdominal surgery for cancer, including for example radical cystectomy, nephrectomy, colectomy, comparing a control group that uses a wearable device to track physical activity to an intervention group that us...
What is the current status of trial NCT04314778?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2019-11-15. Estimated completion is 2022-08-15.
What conditions does trial NCT04314778 study?
This clinical trial studies the following conditions: Bladder Cancer.
What interventions are being tested in trial NCT04314778?
The interventions under investigation include: social incentive-based gamification (BEHAVIORAL).
Who is sponsoring clinical trial NCT04314778?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04314778 being conducted?
This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bladder Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Home Intravenous Fluid Infusion After Undergoing Radical Cystectomy
RECRUITING · NA
-
CONFIRM: Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
RECRUITING · NA
-
Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.